Drug Trial Radar · NCT02872116
Efficacy Study of Nivolumab Plus Ipilimumab or Nivolumab Plus Chemotherapy Against Chemotherapy in Stomach Cancer or Stomach/Esophagus Junction Cancer
Last checked: Nov 19, 2026Latest source record: Aug 7, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
2,031
Actual
Start
Oct 12, 2016
Primary completion
May 27, 2020
Study completion Jun 6, 2024
Sponsor
- Lead sponsor
- Bristol-Myers SquibbBristol Myers Squibb (BMY)
- Sponsor type
- Industry
- Collaborators
- Ono Pharmaceutical Co., Ltd.
- First posted
- Aug 19, 2016
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The main purpose of this study is to compare how long patients with gastric or gastroesophageal junction cancer live after receiving nivolumab and ipilimumab or nivolumab and chemotherapy compared with patients receiving chemotherapy alone.
Conditions
- Gastric Cancer
- Gastroesophageal Junction Cancer
- Esophageal Adenocarcinoma
Interventions
NivolumabDrug
Specified dose on specified days
IpilimumabDrug
Specified dose on specified days
OxaliplatinDrug
Specified dose on specified days
CapecitabineDrug
Specified dose on specified days
LeucovorinDrug
Specified dose on specified days
FluorouracilDrug
Specified dose on specified days
Primary outcomes
What the sponsor says the trial is designed to measure.
- Overall Survival (OS) in Participants Treated With Nivolumab Plus Chemotherapy vs Chemotherapy With PD-L1 CPS ≥ 5Time frame: From the date of randomization up to the date of death, up to approximately 17 months
- Progression Free Survival (PFS) in Participants Treated With Nivolumab Plus Chemotherapy vs Chemotherapy With PD-L1 CPS ≥ 5Time frame: From randomization to the date of the first documented progressive disease (PD) per BICR or death due to any cause (up to approximately 10 months)
Locations
179 sites in 29 countries. Site status is shown where the registry gives one.
Local Institution - 0005
Los Angeles, California
Local Institution - 0001
San Francisco, California
Local Institution - 0066
Aurora, Colorado
Local Institution - 0151
Denver, Colorado
Local Institution - 0136
Washington D.C., District of Columbia
Florida Cancer Specialists S.
Fort Myers, Florida
Local Institution - 0147
Miami, Florida
Florida Cancer Specialists
St. Petersburg, Florida
Local Institution - 0179
Marietta, Georgia
Local Institution - 0219
Arlington Heights, Illinois
Local Institution - 0120
Chicago, Illinois
Local Institution - 0021
Baltimore, Maryland
Local Institution - 0002
Boston, Massachusetts
Local Institution - 0135
Boston, Massachusetts
Local Institution - 0003
New York, New York
Local Institution - 0138
Cleveland, Ohio
Local Institution - 0186
Cleveland, Ohio
Local Institution - 0146
Eugene, Oregon
Lehigh Valley Health Network
Allentown, Pennsylvania
Local Institution - 0065
Pittsburgh, Pennsylvania
Local Institution - 0104
Nashville, Tennessee
Local Institution - 0140
Bedford, Texas
Local Institution - 0143
Dallas, Texas
Local Institution - 0213
Dallas, Texas
Local Institution - 0004
Houston, Texas
Texas Oncology-Plano East
Plano, Texas
Local Institution - 0150
Newport News, Virginia
Local Institution - 0027
Córdoba, Argentina
Local Institution - 0184
La Rioja, Argentina
Local Institution - 0183
Viedma, Argentina
Local Institution - 0030
Caba, Buenos Aires, Argentina
Local Institution - 0028
Capital Federal, Buenos Aires, Argentina
Local Institution - 0029
Capital Federal, Buenos Aires, Argentina
Local Institution - 0026
San Miguel de Tucumán, Tucumán Province, Argentina
Local Institution - 0202
Blacktown, New South Wales, Australia
Local Institution - 0100
Gosford, New South Wales, Australia
Local Institution - 0190
Southport, Queensland, Australia
Local Institution - 0101
Adelaide, South Australia, Australia
Local Institution - 0103
Ballarat, Victoria, Australia
Local Institution - 0102
Shepparton, Victoria, Australia
Showing 40 of 179 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.